91 related articles for article (PubMed ID: 16503705)
1. Early impact of methadone induction for heroin dependence: differential effects of two dose sequences in a randomized controlled study.
Greenwald MK
Exp Clin Psychopharmacol; 2006 Feb; 14(1):52-67. PubMed ID: 16503705
[TBL] [Abstract][Full Text] [Related]
2. Heroin craving and drug use in opioid-maintained volunteers: effects of methadone dose variations.
Greenwald MK
Exp Clin Psychopharmacol; 2002 Feb; 10(1):39-46. PubMed ID: 11866251
[TBL] [Abstract][Full Text] [Related]
3. Scopolamine detoxification technique for heroin dependence: a randomized trial.
Liu S; Li L; Shen W; Shen X; Yang G; Zhou W
CNS Drugs; 2013 Dec; 27(12):1093-102. PubMed ID: 24092568
[TBL] [Abstract][Full Text] [Related]
4. Effects of a single 50% extra dose of methadone on heroin craving and mood in lower- versus higher-dose methadone patients.
Strasser J; Wiesbeck GA; Meier N; Stohler R; Dürsteler-Macfarland KM
J Clin Psychopharmacol; 2010 Aug; 30(4):450-4. PubMed ID: 20571436
[TBL] [Abstract][Full Text] [Related]
5. A randomized investigation of methadone doses at or over 100 mg/day, combined with contingency management.
Kennedy AP; Phillips KA; Epstein DH; Reamer DA; Schmittner J; Preston KL
Drug Alcohol Depend; 2013 Jun; 130(1-3):77-84. PubMed ID: 23195924
[TBL] [Abstract][Full Text] [Related]
6. Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers.
Donny EC; Brasser SM; Bigelow GE; Stitzer ML; Walsh SL
Addiction; 2005 Oct; 100(10):1496-509. PubMed ID: 16185211
[TBL] [Abstract][Full Text] [Related]
7. Self-reported cravings for heroin and cocaine during maintenance treatment with slow-release oral morphine compared with methadone: a randomized, crossover clinical trial.
Falcato L; Beck T; Reimer J; Verthein U
J Clin Psychopharmacol; 2015 Apr; 35(2):150-7. PubMed ID: 25679130
[TBL] [Abstract][Full Text] [Related]
8. Low (40 mg) versus high (80 mg) dose methadone in a 180-day heroin detoxification program.
Banys P; Tusel DJ; Sees KL; Reilly PM; Delucchi KL
J Subst Abuse Treat; 1994; 11(3):225-32. PubMed ID: 8072050
[TBL] [Abstract][Full Text] [Related]
9. High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans.
Donny EC; Walsh SL; Bigelow GE; Eissenberg T; Stitzer ML
Psychopharmacology (Berl); 2002 May; 161(2):202-12. PubMed ID: 11981600
[TBL] [Abstract][Full Text] [Related]
10. The acceptability, safety, and tolerability of methadone/naloxone in a 50:1 ratio.
Bell J; Shearer J; Ryan A; Graham R; Korompay K; Rizzo S; Sindhusake D; Somogyi AA
Exp Clin Psychopharmacol; 2009 Jun; 17(3):146-53. PubMed ID: 19586229
[TBL] [Abstract][Full Text] [Related]
11. Transferring methadone-maintained outpatients to the buprenorphine sublingual tablet: a preliminary study.
Greenwald MK; Schuh KJ; Stine SM
Am J Addict; 2003; 12(4):365-74. PubMed ID: 14504028
[TBL] [Abstract][Full Text] [Related]
12. Long-term methadone maintenance reduces protracted symptoms of heroin abstinence and cue-induced craving in Chinese heroin abusers.
Shi J; Zhao LY; Epstein DH; Zhang XL; Lu L
Pharmacol Biochem Behav; 2007 May; 87(1):141-5. PubMed ID: 17532034
[TBL] [Abstract][Full Text] [Related]
13. Craving and self-efficacy in the first five weeks of methadone maintenance therapy: a daily process study.
Barta WD; Kurth ME; Stein MD; Tennen H; Kiene SM
J Stud Alcohol Drugs; 2009 Sep; 70(5):735-40. PubMed ID: 19737498
[TBL] [Abstract][Full Text] [Related]
14. Choice between heroin and food in nondependent and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine, and methadone.
Negus SS
J Pharmacol Exp Ther; 2006 May; 317(2):711-23. PubMed ID: 16456085
[TBL] [Abstract][Full Text] [Related]
15. Illicit use of methadone in heroin addicts in Rome.
Grassi MC; Nencini P; Paroli E
Ann Ist Super Sanita; 1991; 27(4):671-4. PubMed ID: 1820739
[TBL] [Abstract][Full Text] [Related]
16. Reduced responses to heroin-cue-induced craving in the dorsal striatum: effects of long-term methadone maintenance treatment.
Wang Y; Wang H; Li W; Zhu J; Gold MS; Zhang D; Wang L; Li Y; Yan X; Cheng J; Li Q; Wang W
Neurosci Lett; 2014 Oct; 581():120-4. PubMed ID: 25157798
[TBL] [Abstract][Full Text] [Related]
17. Mood and neuroendocrine response to a chemical stressor, metyrapone, in buprenorphine-maintained heroin dependence.
Kakko J; von Wachenfeldt J; Svanborg KD; Lidström J; Barr CS; Heilig M
Biol Psychiatry; 2008 Jan; 63(2):172-7. PubMed ID: 17850768
[TBL] [Abstract][Full Text] [Related]
18. The Effects of Oxytocin on Withdrawal, Craving and Stress Response in Heroin-Dependent Patients: A Randomized, Double-Blind Clinical Trial.
Moeini M; Omidi A; Sehat M; Banafshe HR
Eur Addict Res; 2019; 25(1):41-47. PubMed ID: 30630161
[TBL] [Abstract][Full Text] [Related]
19. Tramadol versus methadone for treatment of opiate withdrawal: a double-blind, randomized, clinical trial.
Zarghami M; Masoum B; Shiran MR
J Addict Dis; 2012; 31(2):112-7. PubMed ID: 22540433
[TBL] [Abstract][Full Text] [Related]
20. Heroin anticraving medications: a systematic review.
Fareed A; Vayalapalli S; Casarella J; Amar R; Drexler K
Am J Drug Alcohol Abuse; 2010 Nov; 36(6):332-41. PubMed ID: 20955107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
